notablelabs.com - NTBL EV/Sales Multiple

Notable Labs, Ltd. (NTBL) supports ESG goals by optimizing medication consumption through precise therapy selection. The business model relies on external synthesis and testing, creating a strong dependency on contractors. This niche IT platform is subject to binary risks. The EV/Sales valuation level illustrates the market consensus, while the metric confirms the company's current valuation relative to its revenue.
Financial and market metric breakdowns for Notable Labs Inc. (NTBL)

The assessment of Notable Labs, Ltd. (NTBL) resilience to market shocks depends on the balance between capitalization and revenue, which is critical for an R&D platform specializing in oncology screening automation. Analyzing the EV/Sales multiple, which combines market value and net debt, allows for the identification of asset overvaluation relative to the industry, where a prolonged elevated metric signals a risk of sharp price correction.